AI Powered Business Intelligence for Life Science Leaders: Save Time, Drive Adoption and Scale Faster
Timely business insights hold the key to successfully competing in an increasingly digital world. Life sciences companies have invested millions in legacy business intelligence (BI) tools to deliver those insights to their commercial teams; however, they have failed to maximize ROI from those solutions characterized by limited scalability and low user adoption. Artificial intelligence (AI)-powered BI platforms provide life sciences companies with game-changing capabilities. These next-generation tools deliver cognitive insights based on billions of records in a matter of seconds – by simply asking a question in natural language. An AI-powered cognitive insights platform can finally enable life sciences companies to provide easy access to the information – their commercial teams need the most – when they need it. Complete this brief form to download our white paper ‘AI Powered Business Intelligence for Life Science Leaders: Save Time, Drive Adoption and Scale Faster’ to learn:
- Barriers that prevent life sciences organizations from easily accessing data-driven insights
- The advantages of a next-generation cognitive insights platform over legacy BI tools
- The impact pre-trained AI for life sciences can have on performance and total cost of ownership (TCO)
- New functionality that AI offers, including proactive insights and automatic alerts based on user behaviors
Cognitive insights platforms increase productivity by 5x, increase user adoption to 100%, reduce dependency on IT by 40% and reduce the TCO by 50%.
When it comes to data analytics and actionable insights, a cognitive insights platform will make life sciences companies unstoppable.
Download your E-Book
Download your Whitepaper
People also viewed
A New Era of Personalization: Applying Generative AI to Dynamic Customer Engagement
Webinar Series: Part 4 - Give Your Life Sciences Analytics the ExplAIn Advantage
Adding Up Data Analytics Total Cost of Ownership (TCO) and How to Lower It
High data analytics expenditures don’t have to be a cost of doing business for life sciences companies. WhizAI lowers the total cost of ownership (TCO) while making data insights more accessible to business users. Traditionally, data analytics TCO has been a significant expense for life sciences organizations.
Transforming Life Sciences Commercial Function with AI and Augmented Analytics
In this whitepaper, sponsored by WhizAl, Everest Group explores the business case and profound impact Al and Augmented Analytics can have on the life sciences commercial function across various use cases in Sales, Marketing, and Market Access. They examine what top pharma enterprises are looking for in an augmented analytics tool, a roadmap for how to get started, and a blueprint for adoption.
Augmented Analytics is “On the Rise” on Gartner’s 2022 Hype Cycle for Life Science Commercial Operations
The Gartner® 2022 Hype Cycle™ for Life Science Commercial Operations introduces a new category, Augmented Analytics, this year. WhizAI is listed as a sample vendor in the Augmented Analytics category in this Hype Cycle. This summary report covers the following highlights.
Why Domain Expertise Is Essential for Life Science Analytics
Domain expertise matters. Consider this: Enterprises choose transportation and logistics companies that have created the specific types of services they need. Businesses seek professional services with experience in their industries and look for consultants with good track records in their markets. However, remember that domain expertise benefits extend to analytics platforms, particularly those deployed for life sciences.